Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Hospice × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 85 Carcinoma, Non-Small-Cell Lung 69 Prostatic Neoplasms 54 Neoplasms 50 Multiple Myeloma 39 Melanoma 36 Lymphoma 33 Leukemia, Myeloid, Acute 33 Neoplasm Metastasis 29 Lung Neoplasms 28 Leukemia, Lymphocytic, Chronic, B-Cell 28 Colorectal Neoplasms 28 Squamous Cell Carcinoma of Head and Neck 27 Ovarian Neoplasms 22 Triple Negative Breast Neoplasms 21 Hematologic Neoplasms 21 Parkinson Disease 4, Autosomal Dominant Lewy Body 19 Myelodysplastic Syndromes 18 Recurrence 16 Lymphoma, Non-Hodgkin 16 Carcinoma, Hepatocellular 16 Urinary Bladder Neoplasms 15 Lymphoma, Large B-Cell, Diffuse 15 Fallopian Tube Neoplasms 15 Pancreatic Neoplasms 14 Lymphoma, Follicular 14 Head and Neck Neoplasms 14 Brain Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia 13

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡